Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
BATF
|
ENSG00000156127.6 | basic leucine zipper ATF-like transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
BATF | hg19_v2_chr14_+_75988768_75988826 | -0.12 | 5.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_51504411 | 6.14 |
ENST00000593490.1
|
KLK8
|
kallikrein-related peptidase 8 |
chr1_-_153113927 | 5.23 |
ENST00000368752.4
|
SPRR2B
|
small proline-rich protein 2B |
chr18_+_21452964 | 5.06 |
ENST00000587184.1
|
LAMA3
|
laminin, alpha 3 |
chr1_+_150480576 | 5.06 |
ENST00000346569.6
|
ECM1
|
extracellular matrix protein 1 |
chr9_+_33795533 | 4.79 |
ENST00000379405.3
|
PRSS3
|
protease, serine, 3 |
chr2_-_113594279 | 4.54 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
chr18_+_21452804 | 4.27 |
ENST00000269217.6
|
LAMA3
|
laminin, alpha 3 |
chr19_-_51487071 | 4.16 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
chr1_-_113478603 | 4.12 |
ENST00000443580.1
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1 |
chr1_+_150480551 | 4.08 |
ENST00000369049.4
ENST00000369047.4 |
ECM1
|
extracellular matrix protein 1 |
chr1_-_153521597 | 3.82 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
chr12_+_13349650 | 3.47 |
ENST00000256951.5
ENST00000431267.2 ENST00000542474.1 ENST00000544053.1 |
EMP1
|
epithelial membrane protein 1 |
chr1_-_153029980 | 3.43 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
chr1_-_153348067 | 3.32 |
ENST00000368737.3
|
S100A12
|
S100 calcium binding protein A12 |
chr17_-_39769005 | 3.29 |
ENST00000301653.4
ENST00000593067.1 |
KRT16
|
keratin 16 |
chr12_-_52845910 | 3.12 |
ENST00000252252.3
|
KRT6B
|
keratin 6B |
chr1_-_153521714 | 3.04 |
ENST00000368713.3
|
S100A3
|
S100 calcium binding protein A3 |
chr19_-_36019123 | 2.80 |
ENST00000588674.1
ENST00000452271.2 ENST00000518157.1 |
SBSN
|
suprabasin |
chr12_+_8975061 | 2.66 |
ENST00000299698.7
|
A2ML1
|
alpha-2-macroglobulin-like 1 |
chr2_-_113542063 | 2.40 |
ENST00000263339.3
|
IL1A
|
interleukin 1, alpha |
chr9_+_105757590 | 2.32 |
ENST00000374798.3
ENST00000487798.1 |
CYLC2
|
cylicin, basic protein of sperm head cytoskeleton 2 |
chr1_-_153433120 | 2.29 |
ENST00000368723.3
|
S100A7
|
S100 calcium binding protein A7 |
chr1_+_152974218 | 2.23 |
ENST00000331860.3
ENST00000443178.1 ENST00000295367.4 |
SPRR3
|
small proline-rich protein 3 |
chr7_+_48128316 | 2.22 |
ENST00000341253.4
|
UPP1
|
uridine phosphorylase 1 |
chr7_+_48128194 | 2.21 |
ENST00000416681.1
ENST00000331803.4 ENST00000432131.1 |
UPP1
|
uridine phosphorylase 1 |
chr21_+_41029235 | 2.19 |
ENST00000380618.1
|
B3GALT5
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 |
chr19_+_45174994 | 2.16 |
ENST00000403660.3
|
CEACAM19
|
carcinoembryonic antigen-related cell adhesion molecule 19 |
chr14_+_24099318 | 2.15 |
ENST00000432832.2
|
DHRS2
|
dehydrogenase/reductase (SDR family) member 2 |
chr16_-_20681177 | 2.10 |
ENST00000524149.1
|
ACSM1
|
acyl-CoA synthetase medium-chain family member 1 |
chr6_+_74405804 | 2.03 |
ENST00000287097.5
|
CD109
|
CD109 molecule |
chr19_-_14889349 | 2.03 |
ENST00000315576.3
ENST00000392967.2 ENST00000346057.1 ENST00000353876.1 ENST00000353005.1 |
EMR2
|
egf-like module containing, mucin-like, hormone receptor-like 2 |
chr1_+_152956549 | 2.03 |
ENST00000307122.2
|
SPRR1A
|
small proline-rich protein 1A |
chr19_+_45174724 | 2.00 |
ENST00000358777.4
|
CEACAM19
|
carcinoembryonic antigen-related cell adhesion molecule 19 |
chr22_+_31488433 | 1.97 |
ENST00000455608.1
|
SMTN
|
smoothelin |
chr18_+_61442629 | 1.79 |
ENST00000398019.2
ENST00000540675.1 |
SERPINB7
|
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
chr12_-_122238464 | 1.77 |
ENST00000546227.1
|
RHOF
|
ras homolog family member F (in filopodia) |
chr2_+_113875466 | 1.75 |
ENST00000361779.3
ENST00000259206.5 ENST00000354115.2 |
IL1RN
|
interleukin 1 receptor antagonist |
chr5_+_135394840 | 1.65 |
ENST00000503087.1
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
chr16_-_29479154 | 1.64 |
ENST00000549950.1
|
RP11-345J4.3
|
Uncharacterized protein |
chr7_+_142457315 | 1.63 |
ENST00000486171.1
ENST00000311737.7 |
PRSS1
|
protease, serine, 1 (trypsin 1) |
chr1_+_17559776 | 1.61 |
ENST00000537499.1
ENST00000413717.2 ENST00000536552.1 |
PADI1
|
peptidyl arginine deiminase, type I |
chr15_-_80263506 | 1.58 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
chr3_-_47950745 | 1.56 |
ENST00000429422.1
|
MAP4
|
microtubule-associated protein 4 |
chr5_-_150948414 | 1.53 |
ENST00000261800.5
|
FAT2
|
FAT atypical cadherin 2 |
chr3_-_127455200 | 1.53 |
ENST00000398101.3
|
MGLL
|
monoglyceride lipase |
chr1_+_153388993 | 1.52 |
ENST00000368729.4
|
S100A7A
|
S100 calcium binding protein A7A |
chr7_-_24797546 | 1.51 |
ENST00000414428.1
ENST00000419307.1 ENST00000342947.3 |
DFNA5
|
deafness, autosomal dominant 5 |
chr1_-_152386732 | 1.49 |
ENST00000271835.3
|
CRNN
|
cornulin |
chr5_+_150591678 | 1.48 |
ENST00000523466.1
|
GM2A
|
GM2 ganglioside activator |
chr19_+_6531010 | 1.48 |
ENST00000245817.3
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9 |
chr13_+_78109884 | 1.47 |
ENST00000377246.3
ENST00000349847.3 |
SCEL
|
sciellin |
chr11_-_65667997 | 1.46 |
ENST00000312562.2
ENST00000534222.1 |
FOSL1
|
FOS-like antigen 1 |
chrX_+_135251783 | 1.44 |
ENST00000394153.2
|
FHL1
|
four and a half LIM domains 1 |
chr17_+_48712206 | 1.43 |
ENST00000427699.1
ENST00000285238.8 |
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
chr12_-_95009837 | 1.43 |
ENST00000551457.1
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
chr1_+_87012753 | 1.43 |
ENST00000370563.3
|
CLCA4
|
chloride channel accessory 4 |
chr13_+_78109804 | 1.42 |
ENST00000535157.1
|
SCEL
|
sciellin |
chr2_-_31440377 | 1.41 |
ENST00000444918.2
ENST00000403897.3 |
CAPN14
|
calpain 14 |
chrX_+_135251835 | 1.40 |
ENST00000456445.1
|
FHL1
|
four and a half LIM domains 1 |
chrX_+_96138907 | 1.39 |
ENST00000373040.3
|
RPA4
|
replication protein A4, 30kDa |
chr1_+_153003671 | 1.39 |
ENST00000307098.4
|
SPRR1B
|
small proline-rich protein 1B |
chr19_-_51568324 | 1.38 |
ENST00000595547.1
ENST00000335422.3 ENST00000595793.1 ENST00000596955.1 |
KLK13
|
kallikrein-related peptidase 13 |
chr12_-_95510743 | 1.37 |
ENST00000551521.1
|
FGD6
|
FYVE, RhoGEF and PH domain containing 6 |
chr18_+_61445007 | 1.35 |
ENST00000447428.1
ENST00000546027.1 |
SERPINB7
|
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
chr19_-_51538118 | 1.33 |
ENST00000529888.1
|
KLK12
|
kallikrein-related peptidase 12 |
chr11_+_5617858 | 1.33 |
ENST00000380097.3
|
TRIM6
|
tripartite motif containing 6 |
chr17_+_74381343 | 1.32 |
ENST00000392496.3
|
SPHK1
|
sphingosine kinase 1 |
chr13_-_30881134 | 1.31 |
ENST00000380617.3
ENST00000441394.1 |
KATNAL1
|
katanin p60 subunit A-like 1 |
chr2_-_42991257 | 1.31 |
ENST00000378661.2
|
OXER1
|
oxoeicosanoid (OXE) receptor 1 |
chr11_-_65667884 | 1.30 |
ENST00000448083.2
ENST00000531493.1 ENST00000532401.1 |
FOSL1
|
FOS-like antigen 1 |
chr11_-_62323702 | 1.29 |
ENST00000530285.1
|
AHNAK
|
AHNAK nucleoprotein |
chr19_-_51538148 | 1.29 |
ENST00000319590.4
ENST00000250351.4 |
KLK12
|
kallikrein-related peptidase 12 |
chr5_+_73980965 | 1.28 |
ENST00000261416.7
|
HEXB
|
hexosaminidase B (beta polypeptide) |
chr21_-_47604318 | 1.28 |
ENST00000291672.5
ENST00000330205.6 |
SPATC1L
|
spermatogenesis and centriole associated 1-like |
chr1_+_17531614 | 1.27 |
ENST00000375471.4
|
PADI1
|
peptidyl arginine deiminase, type I |
chr12_-_30887948 | 1.27 |
ENST00000433722.2
|
CAPRIN2
|
caprin family member 2 |
chr19_-_51014345 | 1.27 |
ENST00000391815.3
ENST00000594350.1 ENST00000601423.1 |
JOSD2
|
Josephin domain containing 2 |
chr17_-_7493390 | 1.27 |
ENST00000538513.2
ENST00000570788.1 ENST00000250055.2 |
SOX15
|
SRY (sex determining region Y)-box 15 |
chr14_+_56584414 | 1.25 |
ENST00000559044.1
|
PELI2
|
pellino E3 ubiquitin protein ligase family member 2 |
chr20_+_36012051 | 1.23 |
ENST00000373567.2
|
SRC
|
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog |
chr15_-_74501360 | 1.23 |
ENST00000323940.5
|
STRA6
|
stimulated by retinoic acid 6 |
chr19_+_56368803 | 1.22 |
ENST00000587891.1
|
NLRP4
|
NLR family, pyrin domain containing 4 |
chr15_-_74504597 | 1.20 |
ENST00000416286.3
|
STRA6
|
stimulated by retinoic acid 6 |
chr7_+_129932974 | 1.18 |
ENST00000445470.2
ENST00000222482.4 ENST00000492072.1 ENST00000473956.1 ENST00000493259.1 ENST00000486598.1 |
CPA4
|
carboxypeptidase A4 |
chr1_+_16083154 | 1.17 |
ENST00000375771.1
|
FBLIM1
|
filamin binding LIM protein 1 |
chr14_-_91710852 | 1.17 |
ENST00000535815.1
ENST00000529102.1 |
GPR68
|
G protein-coupled receptor 68 |
chr4_-_80994619 | 1.17 |
ENST00000404191.1
|
ANTXR2
|
anthrax toxin receptor 2 |
chr22_+_23046750 | 1.16 |
ENST00000390307.2
|
IGLV3-22
|
immunoglobulin lambda variable 3-22 (gene/pseudogene) |
chr4_+_69962185 | 1.16 |
ENST00000305231.7
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
chr22_-_37880543 | 1.16 |
ENST00000442496.1
|
MFNG
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
chr15_+_69706585 | 1.16 |
ENST00000559279.1
ENST00000395392.2 |
KIF23
|
kinesin family member 23 |
chr2_-_187713891 | 1.15 |
ENST00000295131.2
|
ZSWIM2
|
zinc finger, SWIM-type containing 2 |
chr4_+_72897521 | 1.15 |
ENST00000308744.6
ENST00000344413.5 |
NPFFR2
|
neuropeptide FF receptor 2 |
chr14_-_24806588 | 1.15 |
ENST00000555591.1
ENST00000554569.1 |
RP11-934B9.3
RIPK3
|
Uncharacterized protein receptor-interacting serine-threonine kinase 3 |
chr15_+_67458357 | 1.14 |
ENST00000537194.2
|
SMAD3
|
SMAD family member 3 |
chr5_+_147648393 | 1.14 |
ENST00000511106.1
ENST00000398450.4 |
SPINK13
|
serine peptidase inhibitor, Kazal type 13 (putative) |
chr1_+_183155373 | 1.13 |
ENST00000493293.1
ENST00000264144.4 |
LAMC2
|
laminin, gamma 2 |
chr19_+_39279838 | 1.13 |
ENST00000314980.4
|
LGALS7B
|
lectin, galactoside-binding, soluble, 7B |
chr19_-_39264072 | 1.13 |
ENST00000599035.1
ENST00000378626.4 |
LGALS7
|
lectin, galactoside-binding, soluble, 7 |
chr12_+_75874460 | 1.12 |
ENST00000266659.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr10_-_90611566 | 1.12 |
ENST00000371930.4
|
ANKRD22
|
ankyrin repeat domain 22 |
chr6_+_63921399 | 1.12 |
ENST00000356170.3
|
FKBP1C
|
FK506 binding protein 1C |
chrX_+_99899180 | 1.10 |
ENST00000373004.3
|
SRPX2
|
sushi-repeat containing protein, X-linked 2 |
chr7_+_127233689 | 1.10 |
ENST00000265825.5
ENST00000420086.2 |
FSCN3
|
fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus) |
chr11_+_121163466 | 1.09 |
ENST00000527762.1
ENST00000534230.1 ENST00000392789.2 |
SC5D
|
sterol-C5-desaturase |
chr10_+_5005598 | 1.08 |
ENST00000442997.1
|
AKR1C1
|
aldo-keto reductase family 1, member C1 |
chr17_-_5138099 | 1.07 |
ENST00000571800.1
ENST00000574081.1 ENST00000399600.4 ENST00000574297.1 |
SCIMP
|
SLP adaptor and CSK interacting membrane protein |
chr12_-_127256772 | 1.06 |
ENST00000536517.1
|
LINC00944
|
long intergenic non-protein coding RNA 944 |
chr15_+_52155001 | 1.06 |
ENST00000544199.1
|
TMOD3
|
tropomodulin 3 (ubiquitous) |
chr2_-_18770812 | 1.06 |
ENST00000359846.2
ENST00000304081.4 ENST00000600945.1 ENST00000532967.1 ENST00000444297.2 |
NT5C1B
NT5C1B-RDH14
|
5'-nucleotidase, cytosolic IB NT5C1B-RDH14 readthrough |
chr19_-_51523412 | 1.06 |
ENST00000391805.1
ENST00000599077.1 |
KLK10
|
kallikrein-related peptidase 10 |
chr16_-_84538218 | 1.05 |
ENST00000562447.1
ENST00000565765.1 ENST00000535580.1 ENST00000343629.6 |
TLDC1
|
TBC/LysM-associated domain containing 1 |
chr15_+_67418047 | 1.03 |
ENST00000540846.2
|
SMAD3
|
SMAD family member 3 |
chr19_-_16045619 | 1.03 |
ENST00000402119.4
|
CYP4F11
|
cytochrome P450, family 4, subfamily F, polypeptide 11 |
chrX_+_64887512 | 1.02 |
ENST00000360270.5
|
MSN
|
moesin |
chr5_+_159848854 | 1.01 |
ENST00000517480.1
ENST00000520452.1 ENST00000393964.1 |
PTTG1
|
pituitary tumor-transforming 1 |
chr11_-_19082216 | 1.00 |
ENST00000329773.2
|
MRGPRX2
|
MAS-related GPR, member X2 |
chr11_+_65779283 | 1.00 |
ENST00000312134.2
|
CST6
|
cystatin E/M |
chr1_-_151965048 | 0.99 |
ENST00000368809.1
|
S100A10
|
S100 calcium binding protein A10 |
chr2_+_208576259 | 0.99 |
ENST00000392209.3
|
CCNYL1
|
cyclin Y-like 1 |
chr14_+_21510385 | 0.99 |
ENST00000298690.4
|
RNASE7
|
ribonuclease, RNase A family, 7 |
chr6_-_150346607 | 0.99 |
ENST00000367341.1
ENST00000286380.2 |
RAET1L
|
retinoic acid early transcript 1L |
chr2_-_85637459 | 0.99 |
ENST00000409921.1
|
CAPG
|
capping protein (actin filament), gelsolin-like |
chr2_+_87755054 | 0.98 |
ENST00000423846.1
|
LINC00152
|
long intergenic non-protein coding RNA 152 |
chr14_+_20937538 | 0.98 |
ENST00000361505.5
ENST00000553591.1 |
PNP
|
purine nucleoside phosphorylase |
chr15_-_74504560 | 0.98 |
ENST00000449139.2
|
STRA6
|
stimulated by retinoic acid 6 |
chr12_-_48152853 | 0.98 |
ENST00000171000.4
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr1_+_26605618 | 0.97 |
ENST00000270792.5
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3 |
chr17_+_71228793 | 0.97 |
ENST00000426147.2
|
C17orf80
|
chromosome 17 open reading frame 80 |
chr5_+_148521046 | 0.96 |
ENST00000326685.7
ENST00000356541.3 ENST00000309868.7 |
ABLIM3
|
actin binding LIM protein family, member 3 |
chr1_+_203595903 | 0.95 |
ENST00000367218.3
ENST00000367219.3 ENST00000391954.2 |
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4 |
chr19_-_43382142 | 0.95 |
ENST00000597058.1
|
PSG1
|
pregnancy specific beta-1-glycoprotein 1 |
chr17_-_76921459 | 0.95 |
ENST00000262768.7
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
chr3_+_128779610 | 0.95 |
ENST00000307395.4
|
GP9
|
glycoprotein IX (platelet) |
chr15_+_69706643 | 0.95 |
ENST00000352331.4
ENST00000260363.4 |
KIF23
|
kinesin family member 23 |
chr4_-_10023095 | 0.94 |
ENST00000264784.3
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9 |
chr17_+_73717407 | 0.94 |
ENST00000579662.1
|
ITGB4
|
integrin, beta 4 |
chr1_+_203595689 | 0.94 |
ENST00000357681.5
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4 |
chr7_+_80275953 | 0.94 |
ENST00000538969.1
ENST00000544133.1 ENST00000433696.2 |
CD36
|
CD36 molecule (thrombospondin receptor) |
chr11_-_82708519 | 0.93 |
ENST00000534301.1
|
RAB30
|
RAB30, member RAS oncogene family |
chr12_-_48152611 | 0.93 |
ENST00000389212.3
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr11_+_111126707 | 0.92 |
ENST00000280325.4
|
C11orf53
|
chromosome 11 open reading frame 53 |
chr7_+_134528635 | 0.92 |
ENST00000445569.2
|
CALD1
|
caldesmon 1 |
chr2_+_233897382 | 0.92 |
ENST00000233840.3
|
NEU2
|
sialidase 2 (cytosolic sialidase) |
chr2_-_89545079 | 0.91 |
ENST00000468494.1
|
IGKV2-30
|
immunoglobulin kappa variable 2-30 |
chr17_-_76870222 | 0.91 |
ENST00000585421.1
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
chr19_-_11266471 | 0.91 |
ENST00000592540.1
|
SPC24
|
SPC24, NDC80 kinetochore complex component |
chr19_-_22379753 | 0.91 |
ENST00000397121.2
|
ZNF676
|
zinc finger protein 676 |
chr12_+_110011571 | 0.91 |
ENST00000539696.1
ENST00000228510.3 ENST00000392727.3 |
MVK
|
mevalonate kinase |
chr7_+_80231466 | 0.91 |
ENST00000309881.7
ENST00000534394.1 |
CD36
|
CD36 molecule (thrombospondin receptor) |
chr19_-_16045665 | 0.90 |
ENST00000248041.8
|
CYP4F11
|
cytochrome P450, family 4, subfamily F, polypeptide 11 |
chr6_-_131277510 | 0.90 |
ENST00000525193.1
ENST00000527659.1 |
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
chr18_+_61254570 | 0.90 |
ENST00000344731.5
|
SERPINB13
|
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
chr2_+_201450591 | 0.90 |
ENST00000374700.2
|
AOX1
|
aldehyde oxidase 1 |
chr7_+_80275752 | 0.90 |
ENST00000419819.2
|
CD36
|
CD36 molecule (thrombospondin receptor) |
chr4_-_143227088 | 0.90 |
ENST00000511838.1
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa |
chr2_-_85641162 | 0.89 |
ENST00000447219.2
ENST00000409670.1 ENST00000409724.1 |
CAPG
|
capping protein (actin filament), gelsolin-like |
chr20_+_43803517 | 0.89 |
ENST00000243924.3
|
PI3
|
peptidase inhibitor 3, skin-derived |
chr4_-_39033963 | 0.89 |
ENST00000381938.3
|
TMEM156
|
transmembrane protein 156 |
chr5_+_149877334 | 0.89 |
ENST00000523767.1
|
NDST1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
chr12_+_75874580 | 0.89 |
ENST00000456650.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr2_-_106013400 | 0.88 |
ENST00000409807.1
|
FHL2
|
four and a half LIM domains 2 |
chr11_+_46193466 | 0.88 |
ENST00000533793.1
|
RP11-702F3.3
|
RP11-702F3.3 |
chr2_+_87754989 | 0.87 |
ENST00000409898.2
ENST00000419680.2 ENST00000414584.1 ENST00000455131.1 |
LINC00152
|
long intergenic non-protein coding RNA 152 |
chr6_+_106534192 | 0.87 |
ENST00000369091.2
ENST00000369096.4 |
PRDM1
|
PR domain containing 1, with ZNF domain |
chr19_-_43702231 | 0.87 |
ENST00000597374.1
ENST00000599371.1 |
PSG4
|
pregnancy specific beta-1-glycoprotein 4 |
chr6_+_47666275 | 0.87 |
ENST00000327753.3
ENST00000283303.2 |
GPR115
|
G protein-coupled receptor 115 |
chr17_-_41623259 | 0.87 |
ENST00000538265.1
ENST00000591713.1 |
ETV4
|
ets variant 4 |
chr12_-_53594227 | 0.86 |
ENST00000550743.2
|
ITGB7
|
integrin, beta 7 |
chr19_+_15052301 | 0.86 |
ENST00000248072.3
|
OR7C2
|
olfactory receptor, family 7, subfamily C, member 2 |
chr3_-_48632593 | 0.85 |
ENST00000454817.1
ENST00000328333.8 |
COL7A1
|
collagen, type VII, alpha 1 |
chr12_-_49351228 | 0.85 |
ENST00000541959.1
ENST00000447318.2 |
ARF3
|
ADP-ribosylation factor 3 |
chr12_-_91573316 | 0.85 |
ENST00000393155.1
|
DCN
|
decorin |
chr9_+_131084846 | 0.85 |
ENST00000608951.1
|
COQ4
|
coenzyme Q4 |
chr7_-_143105941 | 0.85 |
ENST00000275815.3
|
EPHA1
|
EPH receptor A1 |
chr1_-_110283138 | 0.84 |
ENST00000256594.3
|
GSTM3
|
glutathione S-transferase mu 3 (brain) |
chr1_+_24645807 | 0.84 |
ENST00000361548.4
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr9_-_130341268 | 0.84 |
ENST00000373314.3
|
FAM129B
|
family with sequence similarity 129, member B |
chr2_+_87754887 | 0.83 |
ENST00000409054.1
ENST00000331944.6 ENST00000409139.1 |
LINC00152
|
long intergenic non-protein coding RNA 152 |
chr9_+_706842 | 0.83 |
ENST00000382293.3
|
KANK1
|
KN motif and ankyrin repeat domains 1 |
chr14_-_81893734 | 0.82 |
ENST00000555447.1
|
STON2
|
stonin 2 |
chr1_+_24645865 | 0.82 |
ENST00000342072.4
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr12_+_56324756 | 0.82 |
ENST00000331886.5
ENST00000555090.1 |
DGKA
|
diacylglycerol kinase, alpha 80kDa |
chr1_+_86889769 | 0.81 |
ENST00000370565.4
|
CLCA2
|
chloride channel accessory 2 |
chr7_-_100860851 | 0.81 |
ENST00000223127.3
|
PLOD3
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 |
chr12_+_100041527 | 0.80 |
ENST00000324341.1
|
FAM71C
|
family with sequence similarity 71, member C |
chr22_-_37584321 | 0.80 |
ENST00000397110.2
ENST00000337843.2 |
C1QTNF6
|
C1q and tumor necrosis factor related protein 6 |
chr6_-_46703430 | 0.80 |
ENST00000537365.1
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
chr6_+_150070857 | 0.79 |
ENST00000544496.1
|
PCMT1
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase |
chr12_-_33049690 | 0.79 |
ENST00000070846.6
ENST00000340811.4 |
PKP2
|
plakophilin 2 |
chr2_-_220119280 | 0.78 |
ENST00000392088.2
|
TUBA4A
|
tubulin, alpha 4a |
chr11_+_5617976 | 0.78 |
ENST00000445329.1
|
TRIM6
|
tripartite motif containing 6 |
chr3_+_127770455 | 0.78 |
ENST00000464451.1
|
SEC61A1
|
Sec61 alpha 1 subunit (S. cerevisiae) |
chr2_+_102953608 | 0.78 |
ENST00000311734.2
ENST00000409584.1 |
IL1RL1
|
interleukin 1 receptor-like 1 |
chr4_+_156587853 | 0.78 |
ENST00000506455.1
ENST00000511108.1 |
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr11_+_844406 | 0.77 |
ENST00000397404.1
|
TSPAN4
|
tetraspanin 4 |
chr7_+_142031986 | 0.77 |
ENST00000547918.2
|
TRBV7-1
|
T cell receptor beta variable 7-1 (non-functional) |
chr17_-_8113542 | 0.77 |
ENST00000578549.1
ENST00000535053.1 ENST00000582368.1 |
AURKB
|
aurora kinase B |
chr7_-_91764108 | 0.77 |
ENST00000450723.1
|
CYP51A1
|
cytochrome P450, family 51, subfamily A, polypeptide 1 |
chr7_-_38370536 | 0.77 |
ENST00000390343.2
|
TRGV8
|
T cell receptor gamma variable 8 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.5 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
1.4 | 4.1 | GO:0015728 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
1.1 | 4.4 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.9 | 6.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.8 | 3.1 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.7 | 3.7 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.7 | 2.1 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.7 | 4.2 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.6 | 1.9 | GO:1903249 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.6 | 2.5 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.6 | 3.5 | GO:0072564 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.5 | 2.7 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.5 | 2.1 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
0.5 | 2.6 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.5 | 1.9 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.5 | 13.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 2.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.4 | 1.3 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.4 | 2.2 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.4 | 14.3 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.4 | 1.3 | GO:0048627 | myoblast development(GO:0048627) |
0.4 | 1.7 | GO:2000391 | positive regulation of neutrophil extravasation(GO:2000391) |
0.4 | 3.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.4 | 1.2 | GO:0002663 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.4 | 1.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.4 | 1.1 | GO:0055048 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.3 | 0.3 | GO:0045639 | positive regulation of myeloid leukocyte differentiation(GO:0002763) positive regulation of myeloid cell differentiation(GO:0045639) |
0.3 | 2.4 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.3 | 2.0 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.3 | 3.4 | GO:1903944 | negative regulation of myoblast fusion(GO:1901740) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.3 | 0.7 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.3 | 1.0 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.3 | 1.0 | GO:0070637 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.3 | 1.0 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
0.3 | 1.2 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.3 | 1.5 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 0.9 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 0.9 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.3 | 1.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.3 | 0.8 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.3 | 1.7 | GO:0051012 | microtubule sliding(GO:0051012) |
0.3 | 0.8 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.3 | 0.8 | GO:2001248 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.3 | 0.8 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.3 | 0.5 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.2 | 0.7 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.2 | 2.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 1.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.2 | 1.0 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.2 | 1.5 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.2 | 1.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 1.0 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.2 | 18.1 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 4.0 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 0.9 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.2 | 0.7 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.2 | 1.3 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.4 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
0.2 | 0.6 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.2 | 1.0 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.2 | 1.0 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.2 | 2.2 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.2 | 1.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.2 | 5.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.6 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
0.2 | 0.9 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.2 | 0.9 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.2 | 2.2 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.2 | 0.4 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.2 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.5 | GO:0002384 | hepatic immune response(GO:0002384) |
0.2 | 0.5 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.2 | 0.5 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
0.2 | 0.9 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.2 | 0.7 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.2 | 0.7 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.2 | 0.9 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
0.2 | 2.0 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.2 | 0.8 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 0.3 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.2 | 0.7 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) neuron projection maintenance(GO:1990535) |
0.2 | 1.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 0.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 1.3 | GO:0015820 | leucine transport(GO:0015820) |
0.2 | 0.5 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.2 | 1.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.6 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.2 | 0.5 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.2 | 1.3 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.2 | 0.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.2 | 3.8 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.6 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.7 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.1 | 5.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.7 | GO:0035519 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) protein K29-linked ubiquitination(GO:0035519) |
0.1 | 1.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 1.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 2.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.7 | GO:0033383 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
0.1 | 0.1 | GO:0051604 | protein maturation(GO:0051604) |
0.1 | 0.6 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.1 | 0.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.1 | 0.7 | GO:0035549 | positive regulation of interferon-beta secretion(GO:0035549) |
0.1 | 1.0 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.1 | 2.0 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 1.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.4 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.1 | 0.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.1 | 1.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.8 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.1 | 0.8 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.1 | 1.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 0.5 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.1 | 0.4 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.1 | 0.4 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.1 | 0.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 0.9 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.1 | 0.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.3 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.1 | 0.7 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.4 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 1.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.4 | GO:1900217 | pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) thyroid-stimulating hormone secretion(GO:0070460) kidney field specification(GO:0072004) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.1 | 0.5 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 1.0 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
0.1 | 0.4 | GO:0001897 | cytolysis by symbiont of host cells(GO:0001897) hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.1 | 0.2 | GO:1990138 | neuron projection extension(GO:1990138) |
0.1 | 0.4 | GO:0014806 | regulation of muscle hyperplasia(GO:0014738) negative regulation of muscle hyperplasia(GO:0014740) smooth muscle hyperplasia(GO:0014806) |
0.1 | 0.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 1.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.8 | GO:1990539 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.1 | 0.5 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of type IV hypersensitivity(GO:0001808) |
0.1 | 0.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.7 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 0.8 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.5 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.1 | 0.4 | GO:0016598 | protein arginylation(GO:0016598) |
0.1 | 0.4 | GO:0035546 | gamma-delta T cell activation involved in immune response(GO:0002290) interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) regulation of transforming growth factor-beta secretion(GO:2001201) negative regulation of transforming growth factor-beta secretion(GO:2001202) |
0.1 | 0.6 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.1 | 0.4 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.1 | 0.5 | GO:1903524 | positive regulation of blood circulation(GO:1903524) |
0.1 | 0.4 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.1 | 0.5 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.1 | 1.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 1.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.1 | 0.3 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.1 | 0.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 1.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.6 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.1 | 0.6 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.1 | 0.1 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
0.1 | 0.5 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.1 | 0.3 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) regulation of amacrine cell differentiation(GO:1902869) |
0.1 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.3 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.1 | 0.2 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.5 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 0.4 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.1 | 0.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.6 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.3 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.1 | 0.3 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.1 | 0.4 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.1 | 0.2 | GO:0002188 | translation reinitiation(GO:0002188) |
0.1 | 0.5 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.1 | 0.9 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.5 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 1.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.4 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.1 | 0.2 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.1 | 0.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.5 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.3 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 | 2.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 1.1 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.6 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.3 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.4 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.1 | 0.2 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
0.1 | 0.3 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.9 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.1 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.1 | 0.3 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.1 | 0.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 1.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.1 | 0.8 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.1 | 2.8 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 1.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.2 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.1 | 0.6 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.1 | 1.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 2.5 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.1 | 0.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.2 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.1 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 2.0 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.1 | 0.4 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.1 | 0.3 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.1 | 0.2 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.1 | 0.3 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.1 | 0.2 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.1 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.5 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.1 | 1.6 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.2 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.1 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.1 | 0.3 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.1 | 0.6 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.1 | 0.1 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 0.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.2 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.1 | 0.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 1.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.3 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.1 | 0.2 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.5 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.1 | 0.2 | GO:0035483 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
0.1 | 1.0 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.1 | 0.8 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.2 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.1 | 1.0 | GO:0060707 | dorsal/ventral axis specification(GO:0009950) trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.2 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.1 | 0.2 | GO:1901558 | response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.6 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.5 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.2 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.1 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.1 | 0.2 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.2 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.1 | 0.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.3 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 0.3 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.3 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.1 | 1.2 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.7 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.1 | 0.7 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.0 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.0 | 0.1 | GO:0071529 | cementum mineralization(GO:0071529) |
0.0 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.7 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.1 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.0 | 4.4 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.7 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.0 | 0.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.0 | 0.3 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.8 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.0 | 0.7 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 1.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
0.0 | 0.1 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.0 | 0.4 | GO:0042262 | DNA protection(GO:0042262) |
0.0 | 0.0 | GO:2000664 | interleukin-5 secretion(GO:0072603) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) |
0.0 | 0.3 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.0 | 0.8 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.4 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.6 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.0 | 0.3 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.2 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.0 | 0.9 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.3 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.0 | 0.3 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.0 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.2 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.0 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.6 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 0.2 | GO:0007498 | mesoderm development(GO:0007498) |
0.0 | 0.1 | GO:0018011 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.0 | 0.3 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 1.4 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.1 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.0 | 0.1 | GO:0032639 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
0.0 | 0.5 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.3 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.2 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.0 | 0.1 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.0 | 0.1 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
0.0 | 0.2 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.0 | 0.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.1 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
0.0 | 0.3 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.0 | 0.9 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.3 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.0 | 0.3 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.2 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.0 | 0.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 1.7 | GO:2000816 | negative regulation of mitotic sister chromatid separation(GO:2000816) |
0.0 | 0.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.4 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.2 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.0 | 0.6 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.4 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.0 | 1.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.0 | 1.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.2 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.4 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.3 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.7 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.0 | 2.2 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.0 | 0.2 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.0 | 0.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.0 | 0.3 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.0 | 0.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.0 | 0.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.3 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.0 | 0.4 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 0.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 2.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.6 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.3 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.0 | 0.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 1.2 | GO:0030431 | sleep(GO:0030431) |
0.0 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 0.2 | GO:0032606 | regulation of type I interferon production(GO:0032479) type I interferon production(GO:0032606) |
0.0 | 0.1 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.0 | 0.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.1 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.0 | 0.2 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.0 | 0.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.1 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.0 | 4.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 1.1 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.5 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.5 | GO:0007267 | cell-cell signaling(GO:0007267) |
0.0 | 0.2 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.0 | 0.8 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.2 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.0 | 0.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.5 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.0 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 1.2 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.0 | 0.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 1.3 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.1 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.0 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.0 | 0.3 | GO:0043373 | T-helper cell lineage commitment(GO:0002295) alpha-beta T cell lineage commitment(GO:0002363) CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) T-helper 17 cell differentiation(GO:0072539) T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 0.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.0 | 0.2 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.0 | 1.5 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.0 | 0.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.3 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.3 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.1 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.0 | 0.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.0 | GO:0032571 | response to vitamin K(GO:0032571) |
0.0 | 0.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.2 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.0 | 1.6 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.1 | GO:0015811 | L-cystine transport(GO:0015811) |
0.0 | 0.6 | GO:0043153 | photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.5 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.7 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.0 | 0.2 | GO:0060732 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.1 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.0 | 0.2 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.0 | GO:0019563 | glycerol catabolic process(GO:0019563) |
0.0 | 0.1 | GO:0014010 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.0 | 0.1 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.0 | 1.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.0 | 0.2 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0009566 | single fertilization(GO:0007338) fertilization(GO:0009566) |
0.0 | 0.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.4 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.0 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
0.0 | 0.3 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 1.2 | GO:0006195 | purine nucleotide catabolic process(GO:0006195) |
0.0 | 0.2 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.1 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.0 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 1.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.1 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.0 | 0.1 | GO:0072641 | type I interferon secretion(GO:0072641) |
0.0 | 0.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.7 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.1 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.0 | 0.3 | GO:0030334 | regulation of cell migration(GO:0030334) |
0.0 | 0.1 | GO:0032610 | interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.0 | 0.3 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.0 | 0.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.0 | 0.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.4 | GO:0097190 | apoptotic signaling pathway(GO:0097190) |
0.0 | 0.1 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.0 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.1 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.0 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.0 | 0.1 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.7 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.6 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 0.2 |